153 related articles for article (PubMed ID: 30205081)
1. 2,4-Diamino-N10-methylpteroic acid (DAMPA) crystalluria in a patient with osteosarcoma treated with carboxypeptidase-G2 rescue after high-dose methotrexate-induced nephrotoxicity.
Berga F; Luna P; Martorell C; Rey J; Gomila I; Gimenez S; Costa-Bauza A; Elorza MÁ; Sánchez I; Grases F; Barceló B
Clin Chim Acta; 2018 Dec; 487():1-5. PubMed ID: 30205081
[TBL] [Abstract][Full Text] [Related]
2. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
[TBL] [Abstract][Full Text] [Related]
3. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
[TBL] [Abstract][Full Text] [Related]
4. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
[TBL] [Abstract][Full Text] [Related]
5. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
[TBL] [Abstract][Full Text] [Related]
6. Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.
Buchen S; Ngampolo D; Melton RG; Hasan C; Zoubek A; Henze G; Bode U; Fleischhack G
Br J Cancer; 2005 Feb; 92(3):480-7. PubMed ID: 15668713
[TBL] [Abstract][Full Text] [Related]
7. Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2.
Adamson PC; Balis FM; McCully CL; Godwin KS; Bacher JD; Walsh TJ; Poplack DG
J Clin Oncol; 1991 Apr; 9(4):670-4. PubMed ID: 2066764
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.
Widemann BC; Sung E; Anderson L; Salzer WL; Balis FM; Monitjo KS; McCully C; Hawkins M; Adamson PC
J Pharmacol Exp Ther; 2000 Sep; 294(3):894-901. PubMed ID: 10945838
[TBL] [Abstract][Full Text] [Related]
9. Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy.
Krause AS; Weihrauch MR; Bode U; Fleischhack G; Elter T; Heuer T; Engert A; Diehl V; Josting A
Leuk Lymphoma; 2002 Nov; 43(11):2139-43. PubMed ID: 12533039
[TBL] [Abstract][Full Text] [Related]
10. Carboxypeptidase G2 rescue in delayed methotrexate elimination in renal failure.
Mohty M; Peyriere H; Guinet C; Hillaire-Buys D; Blayac JP; Rossi JF
Leuk Lymphoma; 2000 Apr; 37(3-4):441-3. PubMed ID: 10752997
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for monitoring methotrexate in the setting of carboxypeptidase-G2 therapy.
Kumar VS; Law T; Kellogg M
Methods Mol Biol; 2010; 603():359-63. PubMed ID: 20077087
[TBL] [Abstract][Full Text] [Related]
12. Carboxypeptidase G2 rescue after high-dose methotrexate.
DeAngelis LM; Tong WP; Lin S; Fleisher M; Bertino JR
J Clin Oncol; 1996 Jul; 14(7):2145-9. PubMed ID: 8683248
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous Determination of Urine Methotrexate, 7-Hydroxy Methotrexate, Deoxyaminopteroic Acid, and 7-Hydroxy Deoxyaminopteroic Acid by UHPLC-MS/MS in Patients Receiving High-dose Methotrexate Therapy.
Mei S; Cui Y; Zhang D; Zeng C; Ren X; Yu K; Lin S; Zhao Z
Anal Sci; 2020 Dec; 36(12):1479-1483. PubMed ID: 32801284
[TBL] [Abstract][Full Text] [Related]
14. A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma.
Fox E; Busch C; DeBernardo A; Segers B; Gottschalk J; Womer R; Balamuth N; Bagatell R; Balis F
Cancer Chemother Pharmacol; 2021 Jun; 87(6):807-815. PubMed ID: 33677616
[TBL] [Abstract][Full Text] [Related]
15. Understanding and managing methotrexate nephrotoxicity.
Widemann BC; Adamson PC
Oncologist; 2006 Jun; 11(6):694-703. PubMed ID: 16794248
[TBL] [Abstract][Full Text] [Related]
16. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
[TBL] [Abstract][Full Text] [Related]
17. Glucarpidase for the treatment of life-threatening methotrexate overdose.
Tuffaha HW; Al Omar S
Drugs Today (Barc); 2012 Nov; 48(11):705-11. PubMed ID: 23170306
[TBL] [Abstract][Full Text] [Related]
18. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
Tuffaha HW; Al Omar S
J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
[TBL] [Abstract][Full Text] [Related]
19. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
[TBL] [Abstract][Full Text] [Related]
20. DAMPAned Methotrexate: A Case Report and Review of the Management of Acute Methotrexate Toxicity.
Young A; Beriault D; Jung B; Nikonova A; Abosh D; Lee S; Zaltzman J; Perl J
Can J Kidney Health Dis; 2019; 6():2054358119895078. PubMed ID: 31903191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
